Raymond James & Associates’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $34.3M | Buy |
309,960
+21,414
| +7% | +$2.24M | 0.02% | 574 |
|
|
2024
Q2 | $28.4M | Sell |
288,546
-54,915
| -16% | -$5.6M | 0.02% | 617 |
|
|
2024
Q1 | $38.4M | Buy |
343,461
+54,129
| +19% | +$5.84M | 0.03% | 490 |
|
|
2023
Q4 | $29.2M | Buy |
289,332
+34,214
| +13% | +$3.39M | 0.02% | 581 |
|
|
2023
Q3 | $22.1M | Buy |
255,118
+9,277
| +4% | +$839K | 0.02% | 638 |
|
|
2023
Q2 | $23.2M | Sell |
245,841
-7,206
| -3% | -$609K | 0.02% | 631 |
|
|
2023
Q1 | $19.1M | Sell |
253,047
-7,537
| -3% | -$569K | 0.02% | 699 |
|
|
2022
Q4 | $20M | Sell |
260,584
-79,127
| -23% | -$6.01M | 0.02% | 663 |
|
|
2022
Q3 | $22.7M | Buy |
339,711
+51,400
| +18% | +$3.26M | 0.02% | 573 |
|
|
2022
Q2 | $15.1M | Buy |
288,311
+41,237
| +17% | +$2.34M | 0.01% | 749 |
|
|
2022
Q1 | $14M | Buy |
247,074
+94,888
| +62% | +$5.08M | 0.01% | 891 |
|
|
2021
Q4 | $7.84M | Sell |
152,186
-51,017
| -25% | -$2.5M | 0.01% | 1247 |
|
|
2021
Q3 | $10.1M | Buy |
203,203
+9,626
| +5% | +$522K | 0.01% | 1053 |
|
|
2021
Q2 | $11.1M | Buy |
193,577
+7,953
| +4% | +$465K | 0.01% | 1017 |
|
|
2021
Q1 | $11.3M | Buy |
185,624
+76,136
| +70% | +$4.2M | 0.01% | 959 |
|
|
2020
Q4 | $5.86M | Buy |
109,488
+6,021
| +6% | +$312K | 0.01% | 1247 |
|
|
2020
Q3 | $4.86M | Sell |
103,467
-2,173
| -2% | -$112K | 0.01% | 1247 |
|
|
2020
Q2 | $5.51M | Buy |
105,640
+11,900
| +13% | +$613K | 0.01% | 1129 |
|
|
2020
Q1 | $4.49M | Sell |
93,740
-20,055
| -18% | -$1.04M | 0.01% | 1107 |
|
|
2019
Q4 | $5.76M | Buy |
113,795
+16,650
| +17% | +$860K | 0.01% | 1168 |
|
|
2019
Q3 | $4.58M | Buy |
97,145
+4,411
| +5% | +$201K | 0.01% | 1276 |
|
|
2019
Q2 | $4.37M | Sell |
92,734
-2,664
| -3% | -$123K | 0.01% | 1291 |
|
|
2019
Q1 | $4.59M | Buy |
95,398
+8,165
| +9% | +$409K | 0.01% | 1234 |
|
|
2018
Q4 | $3.89M | Sell |
87,233
-2,152
| -2% | -$112K | 0.01% | 1228 |
|
|
2018
Q3 | $4.83M | Sell |
89,385
-25,779
| -22% | -$1.32M | 0.01% | 1231 |
|
|
2018
Q2 | $5.62M | Sell |
115,164
-70,368
| -38% | -$3.99M | 0.01% | 1127 |
|
|
2018
Q1 | $11.6M | Buy |
185,532
+31,139
| +20% | +$2.14M | 0.02% | 695 |
|
|
2017
Q4 | $9.46M | Sell |
154,393
-358,752
| -70% | -$22.2M | 0.02% | 789 |
|
|
2017
Q3 | $34.3M | Sell |
513,145
-85,313
| -14% | -$6.03M | 0.07% | 267 |
|
|
2017
Q2 | $46.6M | Buy |
598,458
+12,807
| +2% | +$967K | 0.1% | 195 |
|
|
2017
Q1 | $47.8M | Buy |
585,651
+41,283
| +8% | +$3.25M | 0.11% | 179 |
|
|
2016
Q4 | $39.2M | Sell |
544,368
-561,653
| -51% | -$40.6M | 0.1% | 199 |
|
|
2016
Q3 | $85.9M | Buy |
1,106,021
+170,142
| +18% | +$13.8M | 0.23% | 92 |
|
|
2016
Q2 | $73M | Buy |
935,879
+154,004
| +20% | +$12.3M | 0.23% | 89 |
|
|
2016
Q1 | $64.1M | Buy |
781,875
+16,202
| +2% | +$1.32M | 0.22% | 87 |
|
|
2015
Q4 | $68.4M | Buy |
765,673
+188,840
| +33% | +$16M | 0.24% | 77 |
|
|
2015
Q3 | $44.3M | Buy |
576,833
+128,570
| +29% | +$10.7M | 0.18% | 121 |
|
|
2015
Q2 | $37.5M | Buy |
448,263
+89,808
| +25% | +$7.93M | 0.14% | 153 |
|
|
2015
Q1 | $32.4M | Buy |
358,455
+75,243
| +27% | +$6.48M | 0.14% | 153 |
|
|
2014
Q4 | $22.9M | Buy |
283,212
+20,114
| +8% | +$1.59M | 0.11% | 191 |
|
|
2014
Q3 | $19.7M | Buy |
263,098
+17,219
| +7% | +$1.25M | 0.11% | 191 |
|
|
2014
Q2 | $16.9M | Buy |
245,879
+46,928
| +24% | +$3.19M | 0.1% | 214 |
|
|
2014
Q1 | $13.9M | Sell |
198,951
-25,772
| -11% | -$1.79M | 0.1% | 231 |
|
|
2013
Q4 | $15M | Buy |
224,723
+48,946
| +28% | +$2.99M | 0.11% | 194 |
|
|
2013
Q3 | $9.17M | Buy |
175,777
+14,566
| +9% | +$740K | 0.08% | 286 |
|
|
2013
Q2 | $7.61M | Buy |
+161,211
| New | +$7.36M | 0.07% | 314 |
|
Other funds holding CAH
Raymond James & Associates's CAH Position: Q3 2024 in Review
Raymond James & Associates increased its Cardinal Health (CAH) stake by 7.4% in Q3 2024, buying an estimated $2.24M and bringing the position to 309,960 shares worth $34.3M. The position accounts for 0.02% of the portfolio, ranked #574.
Raymond James & Associates first reported a position in CAH in Q2 2013 and has held it in 46 quarters since. The position peaked at $85.9M in Q3 2016. 1,016 funds tracked by Wall St. Rank hold CAH as of Q3 2024.
- Raymond James & Associates held 309,960 shares of Cardinal Health worth $34.3M as of Q3 2024.
- Raymond James & Associates bought 21,414 Cardinal Health shares in Q3 2024, an estimated $2.24M.
- Cardinal Health made up 0.02% of Raymond James & Associates's portfolio in Q3 2024, its #574 holding.
- Raymond James & Associates first reported a position in Cardinal Health in Q2 2013 and has held it in 46 quarters since.
- Raymond James & Associates's Cardinal Health position peaked at $85.9M in Q3 2016.
- 1,016 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.